Pulse 20transparent
Pulse 20white 20background

Pulse Therapeutics

Pulse has developed a new platform for drug delivery termed Magnetically-Enhanced Diffusion (MED). Its first application will be for stroke.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location St. Louis, MO, US
  • Currency USD
  • Founded 2009
  • Employees 4
  • Website pulsetherapeutics.com

Company Summary

Pulse Therapeutics has developed a platform device technology utilizing a rotating magnetic field and nano-scale iron particles (MicroBeads) for drug delivery. By using both magnetic force and gradient, the technology can enable preferential delivery of its MicroBeads for numerous applications (see video). The company will continue its focus on the treatment of ischemic stroke following a successful first in human experience which ended in 2013.